Benjamin 1999.
Methods | CBA
Characteristics of studies using second site as control: NOT DONE
Follow up:
‐ providers: NOT CLEAR
‐ patients: NOT DONE
Blinded assessment: DONE for HbA1c, NOT CLEAR for process measures
Baseline: DONE for HbA1c, NOT DONE for eye exam, urine test for albumin/protein
Reliable outcomes: DONE for HbA1c, NOT CLEAR for process outcomes
Protection against contamination: DONE unit of analysis error |
|
Participants | Outpatient clinics of Baystate Medical Center, Springfield (US). This Medical Center has a "firm" system that is an academic group practice that includes attending physicians, residents, nurses, a nutritionist and patients. The firm system creates two group practices that are essentially parallel groups of providers and patients. Patients are predominantly minority patients of Hispanic and African‐American descent. (Type 2 diabetes) providers ‐ ? (physicians, residents, nurses, nutritionist) patients ‐ 144 practices ‐ 2 firms | |
Interventions | Intervention group: Professional intervention (distribution of educational materials (guidelines) + educational meetings + local consensus processes + audit and feedback) Control group: usual care Length of intervention: 15 months |
|
Outcomes | PROCESS:
Compliance with standards of care:
‐Annual urine test for albumin/protein
‐Annual cholesterol determination
‐Annual diabetes education
‐Annual dilated retinal exam
‐Annual influenza vaccinations
‐Annual nutrition education PATIENT: HbA1c |
|
Notes | Guidelines were locally developed by residents and faculty ‐directed at adjustments in treatment and monitoring ‐target: improvement of glycaemic control and compliance with recommended standards | |
Risk of bias | ||
Bias | Authors' judgement | Support for judgement |
Allocation concealment? | Unclear risk | D ‐ Not used |